Kura Oncology (KURA) Receivables - Accured (2020 - 2026)
Kura Oncology's Receivables - Accured was $3.6 million in Q2 2026, unchanged from $3.6 million a year earlier and down 16.3% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Receivables - Accured (2020 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Accured at Kura Oncology came in at $3.8 million, up 15.2% from FY2024.
- Receivables - Accured has now increased for three consecutive years, with a five-year compound annual growth rate of 33.4% (FY2020 to FY2025).
- In earlier years, Receivables - Accured was $3.3 million in FY2024 (+200.0%), $1.1 million in FY2023 (+22.2%), $900,000 in FY2022 (-35.7%) and $1.4 million in FY2021 (+55.6%).
- Quarterly Receivables - Accured has moved between $900,000 (Q4 2022) and $4.3 million (Q1 2026) over five years.
- Compared with a year earlier, Receivables - Accured was higher in seven of the last eight quarters, with growth averaging 77.7%.
- The best year-over-year quarter for Receivables - Accured over five years was Q4 2024 (growth of 200.0%); the worst was Q1 2023 (a decline of 43.8%).
- Per Business Quant data, KURA's Receivables - Accured in the three quarters before Q2 2026 was $4.3 million (Q1 2026), $3.8 million (Q4 2025) and $3.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Kura Oncology | 952.70 Mn | 952.70 Mn | 20.63 Mn | 3.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.60 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2020 | 900,000.00 |
API Access
Kura Oncology Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();